Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination drug therapy for fibromyalgia pain
ISRCTN20173707Phase 4Completed
- Sponsor
- Queen's University
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pregabalin and duloxetine in fibromyalgia (FM) (4 arms), sponsored by Queen's University. Primary endpoint: Daily pain intensity. Started Feb 2011; status: completed.
02
Drugs
pregabalinduloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on ISRCTN20173707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN20173707.